Treating the untended: Real-world insights into enfortumab vedotin plus pembrolizumab for frail metastatic urothelial carcinoma patients excluded or underrepresented in clinical trials (GUARDIANS).

Authors: Can Aydogdu, Stefanie Zschaebitz, Thomas Büttner, Marco Julius Schnabel, Christopher Darr, Guenter Niegisch, Nina Holzwarth, Anna-Lisa Volk, Martin Hennig, Katrin Schlack, Subhajit Mandal, Julia Heinzelbecker, Frederik Wessels, Joschka Heil, Philipp Schmucker, Pia Paffenholz, Friedemann Zengerling, Eva Erne, Viktor Grünwald, Jozefina Casuscelli,

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16548

Source: Full article

---

Abstract

e16548